Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Cathie Wood’s ARK ETFs have released their daily trades for Thursday, March 20th, 2025, showcasing a series of strategic buys and sells across the biotech, communications, and technology sectors. The largest transaction of the day was the purchase of 100,706 shares of CRISPR Therapeutics AG (NASDAQ:CRSP), split between ARKK and ARKG ETFs, with a total value of approximately $4.22 million. This move underscores ARK’s continuing confidence in the gene-editing company, adding to its position from previous days.
Another notable trade was the acquisition of 103,028 shares of Iridium Communications Inc (NASDAQ:IRDM), valued at around $2.84 million, distributed across three ARK ETFs: ARKK, ARKQ, and ARKX (NYSE:ARKX). This follows a consistent pattern of investment in Iridium, as ARK has been accumulating shares in the satellite communications firm throughout the week.
ARK also increased its stake in Tesla Inc (NASDAQ:TSLA), with a purchase of 9,351 shares through its ARKK ETF, totaling approximately $2.21 million. This buy reflects a sustained interest in the electric vehicle giant, despite the stock’s volatility.
In the realm of biotechnology, ARK’s ETFs made several key purchases, including 298,652 shares of Absci Corp (NASDAQ:ABSI) for roughly $890,000 through ARKG and 104,341 shares of Intellia Therapeutics Inc (NASDAQ:NTLA) for about $970,000, split between ARKK and ARKG. Additionally, the funds bought 190,153 shares of Pacific Biosciences of California Inc (NASDAQ:PACB) and 161,298 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX), with values of $237,691 and $1.06 million, respectively.
On the selling side, ARK offloaded 4648 shares of Meta Platforms Inc (NASDAQ:META) from its ARKK ETF, amounting to approximately $2.71 million. This sale is part of a broader trend of reducing exposure to the social media conglomerate, following a significant sell-off the previous week. Other sales included smaller positions in Amgen Inc (NASDAQ:AMGN), UiPath Inc (NYSE:PATH), Repare Therapeutics Inc (NASDAQ:RPTX), and Veeva Systems Inc (NYSE:VEEV), with dollar values ranging from $5,305 to $190,081.
Investors following ARK’s movements will note the ETF’s ongoing strategy of focusing on innovative companies with disruptive potential, while tactically adjusting holdings in response to market conditions and company performance. These daily trade reports offer a glimpse into Cathie Wood’s investment philosophy and the dynamic nature of ARK’s portfolio management.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.